18.11.2014 • News

GE Healthcare Life Sciences With New Istanbul Center

GE Healthcare Life Sciences, will open a technology and training laboratory in Istanbul next year to support Turkey's expanding biopharmaceutical and biotechnology industry.

The facility, complementing GE's global network of customer training and technology facilities in the US, UK, China, India and Sweden, will be part of the company's Turkey Innovation Center. It will offer advanced technical training and technology evaluation to the local biopharmaceutical sector, as well as being open to universities as a location for elements of biotechnology degree courses.

Academics, pharmaceutical and biotechnology researchers as well as GE customers from the Middle East and Russia will also have access to the laboratory for small scale research studies.

Turkey plans to expedite the transformation of its healthcare sector through domestic manufacturing of both devices and pharmaceuticals. The country's goal is for local manufacturing to represent 60% of its pharmaceuticals consumption.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.